Metabolic · LOT 2025-01
Tirzepatide
€200/ 20mg vialIn stock
Dual GIP/GLP-1 receptor agonist — a benchmark compound in incretin-based metabolic research.
Request COA →
≥99.0% purityThird-party testedBatch documented
⚠ For research use only · Not for human use · Not FDA approved
Batch specifications
Purity99.0% by HPLC
FormResearch-format vial
Molecular WeightSee COA
StorageRefrigerate 2–8 °C
ReconstitutionSee COA
DocumentationCOA available
CategoryMetabolic
TagsMetabolic
Amino acid sequence
Sequence available on COA request.
